Enumeral Biomedical Holdings, Inc. Proceeds from Notes Payable
Enumeral Biomedical Holdings, Inc. reported Proceeds from Notes Payable of $2.53 million for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2016-11-10
- 2016-09-30: Proceeds from Notes Payable 9 month $2.53M.
| Period end | Proceeds from Notes Payable 9 month |
|---|---|
| 2016-09-30 | $2.53M 10-Q · filed 2016-11-10 |